Welcome to the 3rd Next Generation Lipid-Based Nanoparticles Delivery Summit
Unlock Targeted Lipid Vehicle Therapies with Precision in Cell, Tissue & Organ Specificity
Initially sparked by COVID-19, renewed interest in lipid-based systems for delivery has now evolved. With an escalating clinical demand and the chance to commercialize lipid-based nanoparticles for novel applications and tissue delivery, the spotlight remains on delivery as the key to achieving clinical and commercial success, unlocking new therapeutic horizons.
The 3rd Next Generation Lipid-Based Nanoparticles Delivery Summit is the only event dedicated entirely to lipid-based nanoparticle delivery, where we bring together 120+ experts in LNP non-clinical, delivery, particle engineering, and formulation from the likes of Teressa, Sanofi, MediciBio, CureVac. Together, we're on a mission to revolutionize drug delivery, conquering the intricate challenges of lipid-based nanoparticle delivery beyond RNAs and extending cargos to destinations beyond the liver.
Across 3 days of carefully curated content, experience the cutting edge of innovation as we refine dosing strategies and minimize off-target effects to enhance therapeutic efficacy while reducing toxicity. Stay ahead of the curve with insights into device-formulation compatibility for cutting-edge routes of administration, tailoring delivery methods to your specific target of interest. Unlock the potential of LNPs to reach challenging tissues, customized to suit your unique therapeutic application.
World-Class Speaker Faculty Includes:
Companies Attending Include:
Our Partners:
Other Events In the LNP Development Series:
